You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage 1 or 2 essential hypertension

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

Not yet recruiting
  • Essential Hypertension
  • NW Roselle
  • Captopril 25Mg Tab
  • (no location specified)
Nov 15, 2023

Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)

Active, not recruiting
  • Hypertension
  • Hypertension, Essential
  • Angiotensin (1-7)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University
Jan 2, 2023

Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )

Recruiting
  • Essential Hypertension
  • Fimasartan + Indapamide
  • Fimasartan + Indapamide placebo
  • Bucheon-si, Kyunggi-do, Korea, Republic of
    The Catholic University of Korea, Bucheon St.Mary's Hospital
May 18, 2023

Hypertension, Blood Pressure, Cardiovascular Diseases Trial in Winston-Salem (HIRREM, Continued Current Care)

Active, not recruiting
  • Hypertension
  • +4 more
  • HIRREM
  • Continued Current Care
  • Winston-Salem, North Carolina
    Department of Neurology, Wake Forest School of Medicine
Jul 28, 2022

Hypertension in Pregnancy Trial (BP <130/80mmHg)

Not yet recruiting
  • Hypertension in Pregnancy
  • BP <130/80mmHg
  • (no location specified)
Aug 4, 2023

Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

Not yet recruiting
  • Essential Hypertension
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 26, 2023

Hypertension Trial in Seoul (HCP2102-1, HPP2104-1, HCP2102-2)

Recruiting
  • Hypertension
  • Seoul, Korea, Republic of
    Kyung Hee University Hospital
Jul 31, 2022

Essential Hypertension, Diabetes, Type 2 Trial in Seongnam (ATB-1011, ATB-1012, ATB-1013)

Recruiting
  • Essential Hypertension
  • Diabetes Mellitus, Type 2
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Jan 31, 2023

Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

Not yet recruiting
  • Hypertension,Essential
  • Songling Xuemaikang Capsules
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Oct 17, 2023

Essential Hypertension, Metabolic Cardiovascular Syndrome, Heart Disease Risk Factors Trial in São Paulo (Using the Avatr App)

Active, not recruiting
  • Essential Hypertension
  • +2 more
  • Using the Avatr App
  • São Paulo, Brazil
    Heart Institute (InCor), Hospital das Clinicas do HCFMUSP
Apr 24, 2023

Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Heart Failure
  • +3 more
  • Empagliflozin 10 MG
  • Placebo
  • (no location specified)
Sep 20, 2023

Uncontrolled Stage 2 Hypertension Trial (Renal denervation)

Not yet recruiting
  • Uncontrolled Stage 2 Hypertension
  • Renal denervation
  • (no location specified)
Sep 28, 2022

Hypertension, Essential Trial in Seoul (AD-209, AD-209-1A, AD-209-1B)

Not yet recruiting
  • Hypertension, Essential
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 30, 2022

Essential Hypertension Trial in Seoul (L04RD1, L04TD3)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Aug 7, 2023

Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)

Active, not recruiting
  • Arterial Stiffness
  • +2 more
  • Cardiovascular fitness
  • Prague, Czechia
  • +1 more
Sep 14, 2023

Hypertension Trial in Seoul (HCP1904-3, RLD2001-1)

Recruiting
  • Hypertension
  • Seoul, Korea, Republic of
    Severance Hospital
Jan 6, 2022

Cardiovascular Diseases Trial (RASI and/or a single pill combination based RASI)

Not yet recruiting
  • Cardiovascular Diseases
  • RASI and/or a single pill combination based RASI
  • (no location specified)
Sep 29, 2022

Hypertension Trial in United States (, PF-00489791)

Completed
Has Results
  • Hypertension
  • Los Angeles, California
  • +19 more
Sep 13, 2021

Primary Hypertension, Chronic Kidney Diseases (CKD) Hypertension Trial in China (Renal Denervation System, Antihypertensive

Completed
  • Hypertension
  • Renal Artery Radiofrequency Ablation System (Generator and Catheter )
  • +2 more
  • Beijing, Beijing, China
  • +24 more
Jan 2, 2023

Colorectal Cancer Trial

Completed
  • Colorectal Cancer
    • (no location specified)
    Nov 8, 2023

    Portal Hypertension Trial in Sohag (upper gastrointestinal endoscopy, 1- Complete blood count 2- Coagulation profile)

    Not yet recruiting
    • Portal Hypertension
    • upper gastrointestinal endoscopy
    • 1- Complete blood count 2- Coagulation profile
    • Sohag, Egypt
      Sohag university Hospital
    Oct 23, 2023

    Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)

    Not yet recruiting
    • Hypertension
    • Placebo
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Hypertension,Essential Trial in China (SPH3127 tablet Dose 1, SPH3127 tablet Dose 2, SPH3127 tablet Dose 3)

    Completed
    • Hypertension,Essential
    • SPH3127 tablet Dose 1
    • +3 more
    • Beijing, China
    • +9 more
    Nov 11, 2021

    Essential Hypertension Trial in Worldwide (Aprocitentan 5 mg, Aprocitentan 10 mg, Aprocitentan 25 mg)

    Completed
    Has Results
    • Essential Hypertension
    • Aprocitentan 5 mg
    • +5 more
    • Fort Payne, Alabama
    • +90 more
    Nov 22, 2022

    Pre-hypertension, Cardiovascular Diseases Trial in Chicago (Watermelon Flesh Dose 1, Watermelon Flesh Dose 2, Control)

    Recruiting
    • Pre-hypertension
    • Cardiovascular Diseases
    • Watermelon Flesh Dose 1
    • +2 more
    • Chicago, Illinois
      Clinical Nutrition Research Center
    May 26, 2023